488 related articles for article (PubMed ID: 33001789)
1. Theranostics in Nuclear Medicine: Emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology.
Gomes Marin JF; Nunes RF; Coutinho AM; Zaniboni EC; Costa LB; Barbosa FG; Queiroz MA; Cerri GG; Buchpiguel CA
Radiographics; 2020 Oct; 40(6):1715-1740. PubMed ID: 33001789
[TBL] [Abstract][Full Text] [Related]
2. General Concepts in Theranostics.
Nunes RF; Zuppani RMF; Coutinho AM; Barbosa FG; Sapienza MT; Marin JFG; Buchpiguel CA
PET Clin; 2021 Jul; 16(3):313-326. PubMed ID: 34053576
[TBL] [Abstract][Full Text] [Related]
3. Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine.
Langbein T; Weber WA; Eiber M
J Nucl Med; 2019 Sep; 60(Suppl 2):13S-19S. PubMed ID: 31481583
[TBL] [Abstract][Full Text] [Related]
4. Radioligand Theranostics in the Management of Neuroendocrine Tumors.
Harris AG; Vinik AI; OʼDorisio TM; OʼDorisio MS
Pancreas; 2020; 49(5):599-603. PubMed ID: 32433395
[No Abstract] [Full Text] [Related]
5. Theranostic approaches in nuclear medicine: current status and future prospects.
Filippi L; Chiaravalloti A; Schillaci O; Cianni R; Bagni O
Expert Rev Med Devices; 2020 Apr; 17(4):331-343. PubMed ID: 32157920
[No Abstract] [Full Text] [Related]
6. An introduction to the clinical practice of theranostics in oncology.
Turner JH
Br J Radiol; 2018 Nov; 91(1091):20180440. PubMed ID: 30179054
[TBL] [Abstract][Full Text] [Related]
7. Theranostic Advances in Breast Cancer in Nuclear Medicine.
Vahidfar N; Aghanejad A; Ahmadzadehfar H; Farzanehfar S; Eppard E
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925632
[TBL] [Abstract][Full Text] [Related]
8. [Nuclear medicine diagnostics, therapy and theranostics in the context of modern oncology].
Schaefer N; Prior J
Ther Umsch; 2019 Sep; 76(4):167-172. PubMed ID: 31498036
[TBL] [Abstract][Full Text] [Related]
9. Targeted radionuclide therapy: frontiers in theranostics.
Gallivanone F; Valente M; Savi A; Canevari C; Castiglioni I
Front Biosci (Landmark Ed); 2017 Jun; 22(10):1750-1759. PubMed ID: 28410143
[TBL] [Abstract][Full Text] [Related]
10. Emerging Preclinical and Clinical Applications of Theranostics for Nononcological Disorders.
Assadi M; Jokar N; Yordanova A; Gholamrezanezhad A; Amini A; Abbasi F; Biersack HJ; Amini A; Nabipour I; Ahmadzadehfar H
PET Clin; 2021 Jul; 16(3):429-440. PubMed ID: 34053586
[TBL] [Abstract][Full Text] [Related]
11. Differentiated thyroid cancer theranostics: radioiodine and beyond.
Choudhury PS; Gupta M
Br J Radiol; 2018 Nov; 91(1091):20180136. PubMed ID: 30260232
[TBL] [Abstract][Full Text] [Related]
12. Personalized medicine in oncology, the potential role of nuclear medicine imaging.
Van de Wiele C; Mees G
Curr Pharm Des; 2014; 20(14):2231-3. PubMed ID: 24025097
[No Abstract] [Full Text] [Related]
13. Theranostics and artificial intelligence: new frontiers in personalized medicine.
Belge Bilgin G; Bilgin C; Burkett BJ; Orme JJ; Childs DS; Thorpe MP; Halfdanarson TR; Johnson GB; Kendi AT; Sartor O
Theranostics; 2024; 14(6):2367-2378. PubMed ID: 38646652
[TBL] [Abstract][Full Text] [Related]
14. Radiotheranostics - Precision Medicine in Nuclear Medicine and Molecular Imaging.
Duan H; Iagaru A; Aparici CM
Nanotheranostics; 2022; 6(1):103-117. PubMed ID: 34976584
[TBL] [Abstract][Full Text] [Related]
15. An Impressive Approach in Nuclear Medicine: Theranostics.
Vahidfar N; Eppard E; Farzanehfar S; Yordanova A; Fallahpoor M; Ahmadzadehfar H
PET Clin; 2021 Jul; 16(3):327-340. PubMed ID: 34053577
[TBL] [Abstract][Full Text] [Related]
16. Theranostics and metabolotheranostics for precision medicine in oncology.
Bhujwalla ZM; Kakkad S; Chen Z; Jin J; Hapuarachchige S; Artemov D; Penet MF
J Magn Reson; 2018 Jun; 291():141-151. PubMed ID: 29705040
[TBL] [Abstract][Full Text] [Related]
17. Theranostics in Brain Tumors.
Shooli H; Nemati R; Ahmadzadehfar H; Aboian M; Jafari E; Jokar N; Nabipour I; Dadgar H; Gholamrezanezhad A; Larvie M; Assadi M
PET Clin; 2021 Jul; 16(3):397-418. PubMed ID: 34053584
[TBL] [Abstract][Full Text] [Related]
18. A review on radiomics and the future of theranostics for patient selection in precision medicine.
Keek SA; Leijenaar RT; Jochems A; Woodruff HC
Br J Radiol; 2018 Nov; 91(1091):20170926. PubMed ID: 29947266
[TBL] [Abstract][Full Text] [Related]
19. The Future of Nuclear Medicine as an Independent Specialty.
Czernin J; Sonni I; Razmaria A; Calais J
J Nucl Med; 2019 Sep; 60(Suppl 2):3S-12S. PubMed ID: 31481589
[TBL] [Abstract][Full Text] [Related]
20. Theranostic Outcomes in Clinical Practice of Oncology: What, So What, Now What? What's More.
Turner JH
Cancer Biother Radiopharm; 2019 Apr; 34(3):135-140. PubMed ID: 30973278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
